Analytical Data
-
Gene name
MRCL3
- Application
-
Alternative Names
ML12A_HUMAN; MLC 2B; MLC-2B; MLCB; MRCL3; MYL12A; Myosin regulatory light chain 12A; Myosin regulatory light chain 2; Myosin regulatory light chain 2. nonsarcomeric; Myosin regulatory light chain MRCL3; Myosin regulatory light chain MRLC3; Myosin RLC; Myosin. light polypeptide. regulatory. non sarcomeric (20kD); nonsarcomeric; RLC
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P19105
-
Expression Region
1-171 aa
-
AA Sequence
MSSKRTKTKT KKRPQRATSN VFAMFDQSQI QEFKEAFNMI DQNRDGFIDK EDLHDMLASL GKNPTDEYLD AMMNEAPGPI NFTMFLTMFG EKLNGTDPED VIRNAFACFD EEATGTIQED YLRELLTTMG DRFTDEEVDE LYREAPIDKK GNFNYIEFTR ILKHGAKDKD D
-
Molecular Weight
19.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MRCL3, or Myeloid-related protein C3, is a member of the myeloid-related protein family, which has garnered attention due to its potential roles in immune regulation and disease. Research has indicated that MRCL3 may be involved in various physiological processes, including inflammation, cell signaling, and immune responses, making it a subject of interest for understanding its implications in health and disease. Recombinant MRCL3 proteins are being studied for their functional properties and therapeutic potential, especially in the context of autoimmune diseases, cancer, and infectious diseases. The ability to produce MRCL3 in a recombinant form allows scientists to dissect its biological activities, understand its interaction with other cellular components, and explore its application as a biomarker or therapeutic target. The ongoing research aims to unveil the molecular mechanisms by which MRCL3 influences immune responses and its possible utility in developing novel therapeutic strategies. As more data emerges, the importance of MRCL3 in the immune system and its role in various pathologies are expected to become clearer, potentially leading to innovative approaches in treating related disorders.
